0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Research Report 2025
Published Date: November 2025
|
Report Code: QYRE-Auto-14F20208
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Nicotinamide Mononucleotide NMN Facial Mask Market Research Report 2025
BUY CHAPTERS

Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Research Report 2025

Code: QYRE-Auto-14F20208
Report
November 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nicotinamide Mononucleotide (NMN) Facial Mask Market Size

The global market for Nicotinamide Mononucleotide (NMN) Facial Mask was valued at US$ 52.54 million in the year 2024 and is projected to reach a revised size of US$ 175 million by 2031, growing at a CAGR of 18.7% during the forecast period.

Nicotinamide Mononucleotide (NMN) Facial Mask Market

Nicotinamide Mononucleotide (NMN) Facial Mask Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nicotinamide Mononucleotide (NMN) Facial Mask competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Nicotinamide Mononucleotide (NMN) Facial Mask market refers to the segment of the skincare and facial mask industry in which NMN is positioned as a key active ingredient for anti-aging and skin vitality. NMN (nicotinamide mononucleotide) is a precursor of NAD⁺ and is recognized in cosmetic ingredient databases primarily as an antioxidant used in topical formulations. In NMN facial masks, this molecule is incorporated into sheet masks, hydrogel masks or cream/wash-off masks, usually in combination with collagen, hyaluronic acid, peptides and plant extracts, to claim benefits such as enhanced cellular energy metabolism, improved elasticity, hydration and reduction of fine lines. As a market, it includes any branded facial mask products that prominently feature NMN on the ingredient list, product name or marketing message and that are sold for regular home skincare routines or professional spa use.
The Nicotinamide Mononucleotide (NMN) Facial Mask industry chain runs from upstream producers of cosmetic-grade NMN, auxiliary actives (collagen, hyaluronic acid, peptides, plant extracts), non-woven or hydrogel mask substrates and packaging materials, through midstream cosmetic formulators and OEM/ODM mask manufacturers, to downstream brand owners, online and offline beauty retailers, spas and end-consumers using the masks for premium anti-aging and moisturizing facial care.
In 2024, global Nicotinamide Mononucleotide (NMN) Facial Mask production reached approximately 14.2 million units, with an average global market price of around US$ 3.7 per unit. The global single-line production capacity ranges from 1 to 2 millon units per year. The industry's gross profit margin is approximately 30%-35%.
North American market for Nicotinamide Mononucleotide (NMN) Facial Mask is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nicotinamide Mononucleotide (NMN) Facial Mask is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Nicotinamide Mononucleotide (NMN) Facial Mask include Natuore Recover, Mirailab Bioscience, EffePharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Mononucleotide (NMN) Facial Mask, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide (NMN) Facial Mask.
The Nicotinamide Mononucleotide (NMN) Facial Mask market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nicotinamide Mononucleotide (NMN) Facial Mask market comprehensively. Regional market sizes, concerning products by Type, by Application, by Core Skin Benefit and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicotinamide Mononucleotide (NMN) Facial Mask manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Core Skin Benefit and by regions.

Scope of Nicotinamide Mononucleotide (NMN) Facial Mask Market Report

Report Metric Details
Report Name Nicotinamide Mononucleotide (NMN) Facial Mask Market
Accounted market size in year US$ 52.54 million
Forecasted market size in 2031 US$ 175 million
CAGR 18.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Sheet Masks
  • Hydrogel / jelly Masks
  • Cream / paste-type Masks
  • Others
Segment by Core Skin Benefit
  • Anti-aging NMN masks
  • Hydrating NMN masks
  • Brightening NMN masks
  • Others
Segment by Target Consumer Group
  • 20s–30s Consumers
  • 30s–40s Consumers
  • Men Consumers
  • Others
Segment by Mask Substrate
  • Conventional Non-woven Fabric Masks
  • Bio-cellulose or Ferment-based Masks
  • Hydrogel / film-forming Materials
  • Others
Segment by Application
  • Online
  • Offline
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Natuore Recover, Mirailab Bioscience, EffePharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nicotinamide Mononucleotide (NMN) Facial Mask manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nicotinamide Mononucleotide (NMN) Facial Mask in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nicotinamide Mononucleotide (NMN) Facial Mask Market growing?

Ans: The Nicotinamide Mononucleotide (NMN) Facial Mask Market witnessing a CAGR of 18.7% during the forecast period 2025-2031.

What is the Nicotinamide Mononucleotide (NMN) Facial Mask Market size in 2031?

Ans: The Nicotinamide Mononucleotide (NMN) Facial Mask Market size in 2031 will be US$ 175 million.

Who are the main players in the Nicotinamide Mononucleotide (NMN) Facial Mask Market report?

Ans: The main players in the Nicotinamide Mononucleotide (NMN) Facial Mask Market are Natuore Recover, Mirailab Bioscience, EffePharm

What are the Application segmentation covered in the Nicotinamide Mononucleotide (NMN) Facial Mask Market report?

Ans: The Applications covered in the Nicotinamide Mononucleotide (NMN) Facial Mask Market report are Online, Offline

What are the Type segmentation covered in the Nicotinamide Mononucleotide (NMN) Facial Mask Market report?

Ans: The Types covered in the Nicotinamide Mononucleotide (NMN) Facial Mask Market report are Sheet Masks, Hydrogel / jelly Masks, Cream / paste-type Masks, Others

1 Nicotinamide Mononucleotide (NMN) Facial Mask Market Overview
1.1 Product Definition
1.2 Nicotinamide Mononucleotide (NMN) Facial Mask by Type
1.2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sheet Masks
1.2.3 Hydrogel / jelly Masks
1.2.4 Cream / paste-type Masks
1.2.5 Others
1.3 Nicotinamide Mononucleotide (NMN) Facial Mask by Core Skin Benefit
1.3.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value Comparison by Core Skin Benefit: 2024 VS 2031
1.3.2 Anti-aging NMN masks
1.3.3 Hydrating NMN masks
1.3.4 Brightening NMN masks
1.3.5 Others
1.4 Nicotinamide Mononucleotide (NMN) Facial Mask by Target Consumer Group
1.4.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value Comparison by Target Consumer Group: 2024 VS 2031
1.4.2 20s–30s Consumers
1.4.3 30s–40s Consumers
1.4.4 Men Consumers
1.4.5 Others
1.5 Nicotinamide Mononucleotide (NMN) Facial Mask by Mask Substrate
1.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value Comparison by Mask Substrate: 2024 VS 2031
1.5.2 Conventional Non-woven Fabric Masks
1.5.3 Bio-cellulose or Ferment-based Masks
1.5.4 Hydrogel / film-forming Materials
1.5.5 Others
1.6 Nicotinamide Mononucleotide (NMN) Facial Mask by Application
1.6.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Application (2024 VS 2031)
1.6.2 Online
1.6.3 Offline
1.7 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Size Estimates and Forecasts
1.7.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2020-2031
1.7.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2020-2031
1.7.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Average Price (2020-2031)
1.8 Assumptions and Limitations
2 Nicotinamide Mononucleotide (NMN) Facial Mask Market Competition by Manufacturers
2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nicotinamide Mononucleotide (NMN) Facial Mask, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Facial Mask, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Facial Mask, Product Type & Application
2.7 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Facial Mask, Date of Enter into This Industry
2.8 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Competitive Situation and Trends
2.8.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nicotinamide Mononucleotide (NMN) Facial Mask Players Market Share by Revenue
2.8.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Scenario by Region
3.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region: 2020-2031
3.2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region: 2020-2025
3.2.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region: 2026-2031
3.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region: 2020-2031
3.3.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region: 2020-2025
3.3.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region: 2026-2031
3.4 North America Nicotinamide Mononucleotide (NMN) Facial Mask Market Facts & Figures by Country
3.4.1 North America Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2020-2031)
3.4.3 North America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2020-2031)
3.5.3 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Market Facts & Figures by Region
3.6.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2020-2031)
3.6.3 Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2020-2031)
3.7.3 Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2020-2031)
4.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2020-2025)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2026-2031)
4.1.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2020-2031)
4.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Type (2020-2031)
4.2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Type (2020-2025)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Type (2026-2031)
4.2.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Type (2020-2031)
4.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2020-2031)
5.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2020-2025)
5.1.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2026-2031)
5.1.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2020-2031)
5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Application (2020-2031)
5.2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Application (2020-2025)
5.2.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Application (2026-2031)
5.2.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Application (2020-2031)
5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Natuore Recover
6.1.1 Natuore Recover Company Information
6.1.2 Natuore Recover Description and Business Overview
6.1.3 Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolio
6.1.5 Natuore Recover Recent Developments/Updates
6.2 Mirailab Bioscience
6.2.1 Mirailab Bioscience Company Information
6.2.2 Mirailab Bioscience Description and Business Overview
6.2.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolio
6.2.5 Mirailab Bioscience Recent Developments/Updates
6.3 EffePharm
6.3.1 EffePharm Company Information
6.3.2 EffePharm Description and Business Overview
6.3.3 EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue and Gross Margin (2020-2025)
6.3.4 EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolio
6.3.5 EffePharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Mononucleotide (NMN) Facial Mask Industry Chain Analysis
7.2 Nicotinamide Mononucleotide (NMN) Facial Mask Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Mononucleotide (NMN) Facial Mask Production Mode & Process Analysis
7.4 Nicotinamide Mononucleotide (NMN) Facial Mask Sales and Marketing
7.4.1 Nicotinamide Mononucleotide (NMN) Facial Mask Sales Channels
7.4.2 Nicotinamide Mononucleotide (NMN) Facial Mask Distributors
7.5 Nicotinamide Mononucleotide (NMN) Facial Mask Customer Analysis
8 Nicotinamide Mononucleotide (NMN) Facial Mask Market Dynamics
8.1 Nicotinamide Mononucleotide (NMN) Facial Mask Industry Trends
8.2 Nicotinamide Mononucleotide (NMN) Facial Mask Market Drivers
8.3 Nicotinamide Mononucleotide (NMN) Facial Mask Market Challenges
8.4 Nicotinamide Mononucleotide (NMN) Facial Mask Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Core Skin Benefit, (US$ Million) & (2024 VS 2031)
 Table 3. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Target Consumer Group, (US$ Million) & (2024 VS 2031)
 Table 4. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Mask Substrate, (US$ Million) & (2024 VS 2031)
 Table 5. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 6. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Competitive Situation by Manufacturers in 2024
 Table 7. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units) of Key Manufacturers (2020-2025)
 Table 8. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Manufacturers (2020-2025)
 Table 9. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 10. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Share by Manufacturers (2020-2025)
 Table 11. Global Market Nicotinamide Mononucleotide (NMN) Facial Mask Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 12. Global Key Players of Nicotinamide Mononucleotide (NMN) Facial Mask, Industry Ranking, 2022 VS 2023 VS 2024
 Table 13. Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Facial Mask, Manufacturing Sites & Headquarters
 Table 14. Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Facial Mask, Product Type & Application
 Table 15. Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Facial Mask, Date of Enter into This Industry
 Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 17. Global Nicotinamide Mononucleotide (NMN) Facial Mask by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) Facial Mask as of 2024)
 Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 19. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 20. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2020-2025) & (K Units)
 Table 21. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Region (2020-2025)
 Table 22. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2026-2031) & (K Units)
 Table 23. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Region (2026-2031)
 Table 24. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2020-2025) & (US$ Million)
 Table 25. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Region (2020-2025)
 Table 26. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2026-2031) & (US$ Million)
 Table 27. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Region (2026-2031)
 Table 28. North America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. North America Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2020-2025) & (K Units)
 Table 30. North America Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2026-2031) & (K Units)
 Table 31. North America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2020-2025) & (US$ Million)
 Table 32. North America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2026-2031) & (US$ Million)
 Table 33. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 34. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2020-2025) & (K Units)
 Table 35. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2026-2031) & (K Units)
 Table 36. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2020-2025) & (US$ Million)
 Table 37. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2026-2031) & (US$ Million)
 Table 38. Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 39. Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2020-2025) & (K Units)
 Table 40. Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2026-2031) & (K Units)
 Table 41. Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2020-2025) & (US$ Million)
 Table 42. Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2020-2025) & (K Units)
 Table 45. Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2026-2031) & (K Units)
 Table 46. Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2026-2031) & (US$ Million)
 Table 48. Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2020-2025) & (K Units)
 Table 50. Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2026-2031) & (K Units)
 Table 51. Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2020-2025) & (US$ Million)
 Table 52. Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2026-2031) & (US$ Million)
 Table 53. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units) by Type (2020-2025)
 Table 54. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units) by Type (2026-2031)
 Table 55. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2020-2025)
 Table 56. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2026-2031)
 Table 57. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue (US$ Million) by Type (2020-2025)
 Table 58. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue (US$ Million) by Type (2026-2031)
 Table 59. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Type (2020-2025)
 Table 60. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Type (2026-2031)
 Table 61. Global Nicotinamide Mononucleotide (NMN) Facial Mask Price (US$/Unit) by Type (2020-2025)
 Table 62. Global Nicotinamide Mononucleotide (NMN) Facial Mask Price (US$/Unit) by Type (2026-2031)
 Table 63. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units) by Application (2020-2025)
 Table 64. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units) by Application (2026-2031)
 Table 65. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2020-2025)
 Table 66. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2026-2031)
 Table 67. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue (US$ Million) by Application (2020-2025)
 Table 68. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue (US$ Million) by Application (2026-2031)
 Table 69. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Application (2020-2025)
 Table 70. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Application (2026-2031)
 Table 71. Global Nicotinamide Mononucleotide (NMN) Facial Mask Price (US$/Unit) by Application (2020-2025)
 Table 72. Global Nicotinamide Mononucleotide (NMN) Facial Mask Price (US$/Unit) by Application (2026-2031)
 Table 73. Natuore Recover Company Information
 Table 74. Natuore Recover Description and Business Overview
 Table 75. Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 76. Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Product
 Table 77. Natuore Recover Recent Developments/Updates
 Table 78. Mirailab Bioscience Company Information
 Table 79. Mirailab Bioscience Description and Business Overview
 Table 80. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Product
 Table 82. Mirailab Bioscience Recent Developments/Updates
 Table 83. EffePharm Company Information
 Table 84. EffePharm Description and Business Overview
 Table 85. EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 86. EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Product
 Table 87. EffePharm Recent Developments/Updates
 Table 88. Key Raw Materials Lists
 Table 89. Raw Materials Key Suppliers Lists
 Table 90. Nicotinamide Mononucleotide (NMN) Facial Mask Distributors List
 Table 91. Nicotinamide Mononucleotide (NMN) Facial Mask Customers List
 Table 92. Nicotinamide Mononucleotide (NMN) Facial Mask Market Trends
 Table 93. Nicotinamide Mononucleotide (NMN) Facial Mask Market Drivers
 Table 94. Nicotinamide Mononucleotide (NMN) Facial Mask Market Challenges
 Table 95. Nicotinamide Mononucleotide (NMN) Facial Mask Market Restraints
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nicotinamide Mononucleotide (NMN) Facial Mask
 Figure 2. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Share by Type: 2024 & 2031
 Figure 4. Sheet Masks Product Picture
 Figure 5. Hydrogel / jelly Masks Product Picture
 Figure 6. Cream / paste-type Masks Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Core Skin Benefit, (US$ Million) & (2020-2031)
 Figure 9. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Share by Core Skin Benefit: 2024 VS 2031
 Figure 10. Anti-aging NMN masks Product Picture
 Figure 11. Hydrating NMN masks Product Picture
 Figure 12. Brightening NMN masks Product Picture
 Figure 13. Others Product Picture
 Figure 14. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Target Consumer Group, (US$ Million) & (2020-2031)
 Figure 15. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Share by Target Consumer Group: 2024 VS 2031
 Figure 16. 20s–30s Consumers Product Picture
 Figure 17. 30s–40s Consumers Product Picture
 Figure 18. Men Consumers Product Picture
 Figure 19. Others Product Picture
 Figure 20. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Mask Substrate, (US$ Million) & (2020-2031)
 Figure 21. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Share by Mask Substrate: 2024 VS 2031
 Figure 22. Conventional Non-woven Fabric Masks Product Picture
 Figure 23. Bio-cellulose or Ferment-based Masks Product Picture
 Figure 24. Hydrogel / film-forming Materials Product Picture
 Figure 25. Others Product Picture
 Figure 26. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Value by Application (2020-2031) & (US$ Million)
 Figure 27. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Share by Application: 2024 & 2031
 Figure 28. Online
 Figure 29. Offline
 Figure 30. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 31. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Size (2020-2031) & (US$ Million)
 Figure 32. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales (2020-2031) & (K Units)
 Figure 33. Global Nicotinamide Mononucleotide (NMN) Facial Mask Average Price (US$/Unit) & (2020-2031)
 Figure 34. Nicotinamide Mononucleotide (NMN) Facial Mask Report Years Considered
 Figure 35. Nicotinamide Mononucleotide (NMN) Facial Mask Sales Share by Manufacturers in 2024
 Figure 36. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Share by Manufacturers in 2024
 Figure 37. Global 5 and 10 Largest Nicotinamide Mononucleotide (NMN) Facial Mask Players: Market Share by Revenue in Nicotinamide Mononucleotide (NMN) Facial Mask in 2024
 Figure 38. Nicotinamide Mononucleotide (NMN) Facial Mask Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 39. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 40. North America Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country (2020-2031)
 Figure 41. North America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2020-2031)
 Figure 42. United States Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Canada Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country (2020-2031)
 Figure 45. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2020-2031)
 Figure 46. Germany Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. France Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. U.K. Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Italy Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Russia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Region (2020-2031)
 Figure 52. Asia Pacific Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Region (2020-2031)
 Figure 53. China Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Japan Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. South Korea Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. India Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Australia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Southeast Asia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country (2020-2031)
 Figure 61. Latin America Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2020-2031)
 Figure 62. Mexico Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 63. Brazil Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 64. Argentina Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 65. Colombia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 66. Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country (2020-2031)
 Figure 67. Middle East and Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2020-2031)
 Figure 68. Turkey Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 69. Saudi Arabia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 70. UAE Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 71. Global Sales Market Share of Nicotinamide Mononucleotide (NMN) Facial Mask by Type (2020-2031)
 Figure 72. Global Revenue Market Share of Nicotinamide Mononucleotide (NMN) Facial Mask by Type (2020-2031)
 Figure 73. Global Nicotinamide Mononucleotide (NMN) Facial Mask Price (US$/Unit) by Type (2020-2031)
 Figure 74. Global Sales Market Share of Nicotinamide Mononucleotide (NMN) Facial Mask by Application (2020-2031)
 Figure 75. Global Revenue Market Share of Nicotinamide Mononucleotide (NMN) Facial Mask by Application (2020-2031)
 Figure 76. Global Nicotinamide Mononucleotide (NMN) Facial Mask Price (US$/Unit) by Application (2020-2031)
 Figure 77. Nicotinamide Mononucleotide (NMN) Facial Mask Value Chain
 Figure 78. Channels of Distribution (Direct Vs Distribution)
 Figure 79. Bottom-up and Top-down Approaches for This Report
 Figure 80. Data Triangulation
 Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart